Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

Lilly drops Hanmi-partnered arthritis drug

Lilly drops Hanmi-partnered arthritis drug

Merck KGaA is among the front-runners among companies developing BTK inhibitors for inflammatory diseases, with its evobrutinib progressing to phase IIb testing in rheumatoid arthritis last September, while Bristol-Myers

Merck/Pfizer’s cancer immunotherapy latecomer hits a snag

Merck/Pfizer’s cancer immunotherapy latecomer hits a snag Merck/Pfizer’ s cancer immunotherapy latecomer hits a snag. Bavencio fails a key lung cancer trial. ... Merck KGaA and Pfizer’s catch-up attempt in the checkpoint inhibitor market has hit a setback after their Bavencio drug failed a key lung cancer

After Axovant shock, Roivant pens diabetes deal with Poxel

After Axovant shock, Roivant pens diabetes deal with Poxel After Axovant shock, Roivant pens diabetes deal with Poxel. Acquires Merck Serono’s diabetes candidate imeglimin as part of the deal. ... by Merck Serono for type 2 diabetes, for $35m upfront and a $15m equity investment.

Merck forges closer ties with Cancer Research UK

Merck forges closer ties with Cancer Research UK Merck forges closer ties with Cancer Research UK. Will partake in three research projects covering hit discovery to preclinical candidate selection. ... Researchers at Merck KGaA will join forces with scientists at Cancer Research UK for an early-stage

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...
Emotional Intelligence and Blended Learning in Healthcare
EI and emotional selling are rising up the agenda when it comes to healthcare training. This article outlines how blended learning approaches can help put them into action....

Infographics